LOS ANGELES--(BUSINESS WIRE)--Goldberg Law PC announces that it is investigating USANA Health Sciences, Inc. (“USANA” or the “Company”) (NYSE: USNA) concerning possible violations of federal securities laws.
If you purchased or otherwise acquired USANA shares and would like more information regarding the investigation, we encourage you to click here, or contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 1999 Avenue of the Stars Suite 1100, Los Angeles, CA 90067, at 800-977-7401, to discuss your rights without cost to you. You can also reach us through the firm’s website at http://www.Goldberglawpc.com, or by email at email@example.com.
USANA develops, makes and sells nutritional and personal care products primarily to decrease the threat of chronic degenerative disease. On February 7, 2017, USANA stated that it will be starting an internal investigation of its Chinese subsidiary, BabyCare Ltd. ("BabyCare"). The investigation is in regards to "compliance with the Foreign Corrupt Practices Act" as well as "BabyCare's expense reimbursement policies."
When this information was revealed to the investing public, the value of USANA fell, causing investors harm.
If you have any questions concerning your legal rights, please immediately contact Goldberg Law PC at 800-977-7401, or visit our website at http://www.Goldberglawpc.com, or email us at firstname.lastname@example.org.
Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.